https://roswellpark.broadcastmed.io/p/cf/transplant-and-cellular-therapy-symposium-2024-1
https://roswellpark.broadcastmed.io/p/cf/upstate-new-york-hematology-2025-11
https://roswellpark.broadcastmed.io/p/s/day-one-morning-12
https://roswellpark.broadcastmed.io/p/s/introductionwelcome-13
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-front-line-management-of-dlbcl-and-hgbl-14
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-management-of-fit-transplant-eligible-patients-with-relapsedrefractory-rr-dlbcl-and-hgbl-15
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-management-of-elderly-or-frail-transplant-ineligible-patients-with-relapsedrefractory-rr-dlbcl-and-hgbl-16
https://roswellpark.broadcastmed.io/p/s/interactive-q-and-a-on-dlbclhgbls-17
https://roswellpark.broadcastmed.io/p/s/break-18
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-front-line-management-of-mantle-cell-lymphoma-mcl-19
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-management-of-relapsedrefractory-mantle-cell-lymphoma-rr-mcl-20
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-front-line-management-of-follicular-lymphoma-fl-21
https://roswellpark.broadcastmed.io/p/s/break-22
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-management-of-relapsedrefractory-follicular-lymphoma-23
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-management-of-lymphoplasmacytic-lymphomawaldenstroms-macroglobulinemia-lplwm-24
https://roswellpark.broadcastmed.io/p/s/interactive-q-and-a-on-mcl-fl-and-wm-25
https://roswellpark.broadcastmed.io/p/s/lunch-26
https://roswellpark.broadcastmed.io/p/s/day-one-afternoon-27
https://roswellpark.broadcastmed.io/p/s/pathological-classification-of-lymphoid-malignancies-a-primed-course-for-practicing-physicians-interactive-case-presentations-and-pathology-lecture-28
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-management-of-cutaneous-t-cell-lymphomas-ctcls-29
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-the-management-of-systemic-and-peripheral-t-cell-lymphomas-30
https://roswellpark.broadcastmed.io/p/s/interactive-q-and-a-ctcl-and-systemicptcl-31
https://roswellpark.broadcastmed.io/p/s/break-32
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-in-initial-management-of-hodgkin-lymphoma-33
https://roswellpark.broadcastmed.io/p/s/challenges-in-the-management-for-relapsedrefractory-hodgkin-lymphoma-34
https://roswellpark.broadcastmed.io/p/s/interactive-q-and-a-on-hodgkin-lymphoma-35
https://roswellpark.broadcastmed.io/p/s/closing-remarks-36
https://roswellpark.broadcastmed.io/p/s/day-two-morning-37
https://roswellpark.broadcastmed.io/p/s/introductionshousekeeping-38
https://roswellpark.broadcastmed.io/p/s/ash-2024-updates-in-sickle-cell-disease-and-thalassemia-syndromes-39
https://roswellpark.broadcastmed.io/p/s/management-of-depression-anxiety-and-existential-distress-in-cancer-patients-40
https://roswellpark.broadcastmed.io/p/s/thrombosis-risk-and-prevention-for-patients-with-cancer-41
https://roswellpark.broadcastmed.io/p/s/interactive-q-and-a-on-classical-hematology-and-supportive-care-42
https://roswellpark.broadcastmed.io/p/s/break-43
https://roswellpark.broadcastmed.io/p/s/clinical-practice-changes-for-the-initialfront-line-management-of-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-cllsll-44
https://roswellpark.broadcastmed.io/p/s/the-evolving-treatment-landscape-of-relapsedrefractory-rr-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-cllsll-45
https://roswellpark.broadcastmed.io/p/s/considerations-for-older-adults-with-aggressive-lymphoid-malignancies-46
https://roswellpark.broadcastmed.io/p/s/interactive-q-and-a-on-cllsll-and-geriatric-considerations-47
https://roswellpark.broadcastmed.io/p/s/brunch-48
https://roswellpark.broadcastmed.io/p/s/day-two-afternoon-49
https://roswellpark.broadcastmed.io/p/s/cellular-therapy-for-plasma-cell-disorders-50
https://roswellpark.broadcastmed.io/p/s/cellular-therapy-for-lymphoma-and-lymphoid-leukemias-51
https://roswellpark.broadcastmed.io/p/s/updates-in-bone-marrow-transplantation-52
https://roswellpark.broadcastmed.io/p/s/interactive-q-and-a-on-cellular-therapy-and-bone-marrow-transplantation-53
https://roswellpark.broadcastmed.io/p/s/break-54
https://roswellpark.broadcastmed.io/p/s/clinical-practice-updates-for-chronic-myeloid-leukemia-cml-and-myeloproliferative-neoplasms-mpns-55
https://roswellpark.broadcastmed.io/p/s/an-update-on-myelodysplastic-syndromes-and-clonal-cytopenias-56
https://roswellpark.broadcastmed.io/p/s/clinical-practice-updates-for-acute-myeloid-leukemias-aml-57
https://roswellpark.broadcastmed.io/p/s/interactive-q-and-a-on-cml-and-mpns-mdsccus-and-aml-58
https://roswellpark.broadcastmed.io/p/s/clinical-practice-updates-in-the-initial-management-of-multiple-myeloma-mm-59
https://roswellpark.broadcastmed.io/p/s/how-to-navigate-treatment-options-in-relapsedrefractory-mm-60
https://roswellpark.broadcastmed.io/p/s/interactive-q-and-a-on-multiple-myeloma-and-plasma-cell-disorders-61
https://roswellpark.broadcastmed.io/p/s/closing-remarks-62